Business · 08/12/2025Updated: 10/17/2026 · 1 min read
FDA Revokes Emergency Use Authorization for Genentech's Actemra
Summary
The FDA has revoked the Emergency Use Authorization for Genentech's Actemra, a COVID-19 treatment, due to changes in the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →